Almost all cases of patients with prostate cancer will progress to castration resistance, indicated by increasing serum levels of prostate specific antigen (PSA) despite castrate levels of testosterone and progress to metastases [2]. This evidence concerns the gene KLK3 and Familial prostate cancer.